0001209191-22-021034.txt : 20220324
0001209191-22-021034.hdr.sgml : 20220324
20220324213054
ACCESSION NUMBER: 0001209191-22-021034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220324
FILED AS OF DATE: 20220324
DATE AS OF CHANGE: 20220324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spaventa Andrew
CENTRAL INDEX KEY: 0001859701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40443
FILM NUMBER: 22768091
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Singular Genomics Systems, Inc.
CENTRAL INDEX KEY: 0001850906
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 812948451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE #100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 333-7830
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE #100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-24
0
0001850906
Singular Genomics Systems, Inc.
OMIC
0001859701
Spaventa Andrew
10931 N. TORREY PINES ROAD
SUITE #100
LA JOLLA
CA
92037
1
1
0
0
Chief Executive Officer
Common Stock
2022-03-24
4
J
0
173144
D
0
I
By Axon Holdings, LLC
Common Stock
2022-03-24
4
J
0
9766
A
9766
D
Common Stock
4413571
I
By The Andrew K. Spaventa Living Trust dated April 9, 2014
The shares were distributed on a pro rata basis by Axon Holdings, LLC.
The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The shares were acquired in connection with a pro rata distribution by Axon Holdings, LLC.
/s/ Dalen Meeter, Attorney-in-Fact
2022-03-24